ePRO BI1403-0008 與 Teckro 使用情況與統計

Boehringer Ingelheim ePRO BI1403-0008 is intended to collect patient reported outcomes relating to a clinical trial (BI Trial 1403-0008 – Brightline-1). Patients must be given accounts by a participating site in order to log in to the app.
  • Apple App Store
  • 免費版
  • 醫療

商店排名

- -

Teckro transforms your clinical trial protocol into a hub of communication and collaboration. It’s a digital platform that connects all study stakeholders with the knowledge they need, when they need it. Drugs from trials powered by Teckro have been granted priority review and approval by regulators in the US and Europe. Thousands of investigators and 20,000+ sites around the world rely on Teckro to execute clinical trials from biopharma sponsors, including 12 out of the Top 20 pharma companies. We support all therapeutic areas, all phases, and any trial model, whether traditional, virtual, or a hybrid approach - if Teckro isn't used on your clinical trial, ask your study manager for it.
  • Apple App Store
  • 免費版
  • 醫療

商店排名

- -

ePRO BI1403-0008與 Teckro 比較排名

比較過去 28 天的 ePRO BI1403-0008 排名趨勢與 Teckro

排名

無可用數據

各國 ePRO BI1403-0008 vs. Teckro 排名比較

比較過去 28 天的 ePRO BI1403-0008 排名趨勢與 Teckro

無可顯示數據

使用我們的免費試用版,與所有網站進行比較

立即開始
ePRO BI1403-0008 VS.
Teckro

12月 28, 2024